Treatment of Major Depression With Nortriptyline and Paroxetine in Patients With Ischemic Heart Disease

Abstract

Both treatments were efficacious. Sixty-three percent of all patients improved at least 50%, and of these, 90% met the criteria for remission. Paroxetine was better tolerated than nortriptyline and less likely to produce cardiovascular side effects.